Found 11 matching trials
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
PHASE1Monthly, continuous anti-vegf therapy for patients presenting with active p...
Location
Retina Consultants of Hawaii, Inc
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
PHASE2Idiopathic Parafoveal Telangiectasia (IPT) \[also known as Idiopathic Perif...
Location
Eye Center of Northern Colorado
High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
PHASE1This study investigates the use of a high dose anti-VEGF agent for the trea...
Location
The New York Eye Cancer Center
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
PHASE3This study is a phase 3, double-masked, randomized, study of the efficacy a...
Location
Multiple Locations
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
PHASE4Macular diseases often cases severe visual impairment. Recent clinical intr...
Location
Kagawa University Faculty of Medicine
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
PHASE1This is a 24-month study of ranibizumab (2.0 mg and 1.0 mg) in subjects wit...
Location
Retina Consultants of Hawaii
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
PHASE1The purpose of this study is to evaluate the safety and tolerability of Ran...
Location
Long Island Vitreoretinal Consultants
Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy
PHASE1This Phase I/II study will investigate the safety and tolerability of intra...
Location
Southeast Retina Center
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
PHASE1This is a multicenter, randomized, open-label study. 40 patients will be fo...
Location
Jules Stein Eye Institute
Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions
PHASE1The primary Objective of this study is to evaluate the safety and tolerabil...
Location
Wilmer Eye Institute at Johns Hopkins University